• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    CareDx, Inc. - Common Stock (NQ: CDNA )

    20.61 +0.06 (+0.29%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,790,621
    Open 20.30
    Bid (Size) 20.65 (2)
    Ask (Size) 22.33 (6)
    Prev. Close 20.55
    Today's Range 20.10 - 21.15
    52wk Range 7.420 - 34.84
    Shares Outstanding 52,627,165
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
    From CareDx, Inc.
    Via Business Wire
    BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) and CareDx Collaborate to Enhance TCB008 Cell Therapy Development for AML
    Via Investor Brand Network

    Performance

    YTD
    +72.61%
    +72.61%
    1 Month
    -7.87%
    -7.87%
    3 Month
    -30.44%
    -30.44%
    6 Month
    +46.59%
    +46.59%
    1 Year
    +76.30%
    +76.30%

    More News

    Read More
    CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
    From CareDx, Inc.
    Via Business Wire
    Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    A Closer Look at 5 Analyst Recommendations For CareDx
    Via Benzinga
    5 Analysts Assess CareDx: What You Need To Know
    Via Benzinga
    CareDx to Participate in Upcoming Investor Conferences
    From CareDx, Inc.
    Via Business Wire
    Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
    Via Investor's Business Daily
    Topics Economy Government
    Exposures Interest Rates Political
    CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
    From CareDx, Inc.
    Via Business Wire
    Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
    Via Benzinga
    Topics ETFs Stocks
    Exposures US Equities
    CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology
    From CareDx, Inc.
    Via Business Wire
    CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting
    From CareDx, Inc.
    Via Business Wire
    Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views
    Via Benzinga
    Exposures Fossil Fuels
    CareDx, JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    CareDx Reports Preliminary Financial Results for Third Quarter 2024
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx Appoints Jing Huang Chief Data and AI Officer
    From CareDx, Inc.
    Via Business Wire
    CareDx to Host Investor Day on October 15, 2024
    From CareDx, Inc.
    Via Business Wire
    CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer
    From CareDx, Inc.
    Via Business Wire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.